# POHCA Resuscitation: Evaluation of IM Epinephrine

Study · id `cardio:ct-nct05166343` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05166343](<https://clinicaltrials.gov/study/NCT05166343>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05166343

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 284 participants.

## Technical summary

Registry record NCT05166343. Randomized; no masking; primary purpose supportive care. Start 2024-01-08 (actual); primary completion 2028-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Phase 2/3
- Enrolled: 284 participants (planned count; ClinicalTrials.gov record NCT05166343, source copy `cardio:ctgov-nct05166343-2025-03-11`, retrieved 2026-10-26)
- Started: 2024-01-08 (actual) (ClinicalTrials.gov record NCT05166343, source copy `cardio:ctgov-nct05166343-2025-03-11`, retrieved 2026-10-26)
- Primary completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT05166343, source copy `cardio:ctgov-nct05166343-2025-03-11`, retrieved 2026-10-26)
- Completion: 2029-01 (anticipated) (ClinicalTrials.gov record NCT05166343, source copy `cardio:ctgov-nct05166343-2025-03-11`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT05166343, source copy `cardio:ctgov-nct05166343-2025-03-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05166343-2025-03-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: POHCA Resuscitation: Evaluation of IM Epinephrine
- Acronym: PRIME
- Condition: Pediatric Out-of-Hospital Cardiac Arrest
- Intervention (Drug): Epinephrine Injection
- Lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (`cardio:org-london-health-sciences-centre-research-institute-or-lawson-92e6ca`)

## Provenance

Content hash: 4446015987201a8e0a845974d384429c28acad2ee9daf69a13cd6c34478b0945
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
